Profitable companies and non-Profitable Biotech companies (rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases. In the next five years the distinction between mature biotech companies and large global pharma is likely to disappear as investment in R&D and acquisition start delivering and Market Cap match the large global pharma. Dividend and consolidation could be the future drivers and continue to attract long term investors. Optimism prevails around the future of this sector as a whole which was reflected in the unprecedented rally in shares in 2012.
This trend continued in the next five years driven by launch of Innovative drugs catering to unmet needs in Alzheimer’s, HCV, osteoporosis, RA, Psoriasis, MS, Dyslipidemia, Cystic fibrosis, Cancer and orphan diseases. Drug approvals and label expansion of existing portfolio of launched drugs and data from late stage pipeline drugs should maintain the growth momentum and investors interest.
The early part of the previous decade (2010-20) was spent recovering from the big acquisitions made by this sector but followed by the exercising of some restrain for similar large acquisitions as investors wanted to see the returns reflected in the top-line and EPS. However in- licensing of early or mid stage compounds or small acquisitions continued since the Rising Stars kept throwing the bait by taking risks and innovate using novel technology platforms or validating novel targets for treating diseases.
Patent expiry impact was also modest as majority had “not so easy to copy” biologics and other drugs in their portfolio. They, however were not complacent and were not leaving any stones unturned to meet the challenges as well as exploring emerging market opportunities with local partners. Favorable regulatory environment finally saw biosimilar mAbs entry in regulated markets The optimism of biosimilar players is reflected in the maturing pipeline. Para IV Filing from other generic players continues to pour leaving room for surprises and volatility.
Moving forward the sector should see a strategic rise of the digital mindset and further adoption of transformative and augumentative technologies. While mergers & acquisitions can still expect a sharper focus despite being more traditional, external innovation should result in a meaningful shift in culture through innovative and creative partnerships with both new entrants and less traditional companies.
There will be an increasing demand for even more transparency and disclosure and a need for real relationship-driven partnerships will encroach across all sector stakeholders including regulators, patients, advocacy groups and also to outsourcing players critical to the supply chain. Data will be a dominating force behind new revenue models and crucial to understanding and delivering an exceptional patient experience. Pricing will continue to exert much pressure, increasing access to drugs, growth of gene and cell therapies, and uncertain trade policies will further change the dynamics of the market.
Industry News
- Drug Patent Expirations for the Week of December 22, 2024by DrugPatentWatch – Make Better Decisions on December 24, 2024 at 5:03 am
VICTRELIS (boceprevir) Merck sharp dohme Patent: RE43298 Expiration: Dec 22, 2024 See More … For more information on how DrugPatentWatch Source
- DrugChatter: What are the side effects of vascepa?by DrugChatter on December 20, 2024 at 8:29 am
The Side Effects of Vascepa: A Comprehensive Review What is Vascepa? Vascepa is a prescription-only medication used to... https://www.Drugchatter.com/chat/27526/what-are-the-side-effects-of-vascepa/ Source
- Leveraging a Drug Patent Portfolio for Successby DrugPatentWatch on December 19, 2024 at 11:15 am
A robust drug patent portfolio is not just an asset—it’s a critical tool for success. As companies invest billions in Source
- DrugChatter: What is the patent expiry date for keytruda?by DrugChatter on December 18, 2024 at 7:14 pm
The Patent Expiry Date for Keytruda: What You Need to Know H1: Introduction Keytruda, also known as pembrolizumab, is a... https://www.Drugchatter.com/chat/59076/what-is-the-patent-expiry-date-for-keytruda/ Source
- Effective Drug Patent Prosecution Strategies: Securing Your Pharmaceutical Innovationsby DrugPatentWatch on December 18, 2024 at 4:30 pm
Protecting your intellectual property is paramount. Drug patent prosecution is a complex and critical process that can make or break Source
- The Importance of CDMO Flexibility: Adapting to the Ever-Changing Pharmaceutical Landscapeby DrugPatentWatch on December 17, 2024 at 2:42 pm
Flexibility has become more than just a buzzword – it’s a necessity. Contract Development and Manufacturing Organizations (CDMOs) are at Source
- The Top Biotechnology Research Labs Around the Worldby Yali Friedman on December 17, 2024 at 11:09 am
The Top Biotechnology Research Labs Around the World Biotechnology has revolutionized various fields, from medicine and agriculture to environmental science Source
- DrugChatter: Is lurbinectedin effective against breast cancer?by DrugChatter on December 17, 2024 at 10:37 am
Is Lurbinectedin Effective Against Breast Cancer? Breast cancer is one of the most common types of cancer affecting women... https://www.Drugchatter.com/chat/21969/is-lurbinectedin-effective-against-breast-cancer/ Source
- Biotech Financing: Understanding Dilutionby Yali Friedman on December 16, 2024 at 9:30 pm
Biotech Financing: Understanding Dilution Navigating the complex landscape of biotech financing can be daunting, especially for new entrepreneurs. One of Source
- DrugChatter: Are there any specific foods to avoid with ezetimibe?by DrugChatter on December 16, 2024 at 8:48 pm
Foods to Avoid with Ezetimibe: A Comprehensive Guide Ezetimibe is a medication commonly prescribed to lower cholesterol... https://www.Drugchatter.com/chat/47867/are-there-any-specific-foods-to-avoid-with-ezetimibe/ Source
- Google Patents: Why It’s a Risky Tool for Finding Drug Patentsby DrugPatentWatch on December 16, 2024 at 3:18 pm
When it comes to researching and navigating the complex world of drug patents, inventors and researchers often turn to various Source
- Drug Patent Expirations for the Week of December 15, 2024by DrugPatentWatch – Make Better Decisions on December 16, 2024 at 5:03 am
REMODULIN (treprostinil) United therap Patent: 10,076,505 Expiration: Dec 16, 2024 See More … For more information on how DrugPatentWatch can Source
- Drug Patent Expirations for the Week of December 15, 2024by DrugPatentWatch – Make Better Decisions on December 15, 2024 at 5:03 am
REMODULIN (treprostinil) United therap Patent: 10,076,505 Expiration: Dec 16, 2024 See More … For more information on how DrugPatentWatch can Source
- How to Evaluate CDMO Performance: Key Considerations and Best Practicesby DrugPatentWatch on December 13, 2024 at 4:00 am
The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to outsource various stages of drug development and Source
- How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensingby DrugPatentWatch on December 12, 2024 at 5:10 pm
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand Source
- Biotech Financing: How to Attract Strategic Investorsby Yali Friedman on December 12, 2024 at 3:21 pm
Biotech Financing: How to Attract Strategic Investors In the biotech industry, securing strategic investors is crucial for the development and Source
- Addressing Generic Drug Market Challenges: Strategies for Stability and Affordabilityby DrugPatentWatch on December 12, 2024 at 2:35 pm
The generic drug market in the United States faces significant challenges, including price volatility, supply chain disruptions, and strategies employed Source
- CDMO Selection: The Ultimate Checklistby DrugPatentWatch on December 12, 2024 at 2:19 am
The biopharmaceutical industry has witnessed a significant surge in the number of therapeutic molecules in development, leading to a corresponding Source
- How to Achieve CDMO Operational Excellenceby DrugPatentWatch on December 11, 2024 at 5:24 pm
Achieving operational excellence in a Contract Development and Manufacturing Organization (CDMO) is crucial to ensure the quality and consistency of Source
- Using FDA Product Specific Guidances (PSGs) as a Trigger for Generic Drug Developmentby DrugPatentWatch on December 11, 2024 at 5:05 pm
Generic drugs play a crucial role in providing affordable healthcare options to millions of patients worldwide. One of the key Source
- A new, updated account of poroid fungi in North Americaon September 4, 2024 at 6:31 pm
Poroid fungi, commonly known as “polypores,” are among the most frequently encountered fungi throughout the year because of their large size and longevity. Despite the common presence of poroid fungi in North America, most guides include only a limited selection of these fungi. Poroid Fungi of North America, by Leif Ryvarden, offers a necessary, updated account
- Few anti-immigration users dominate most of UK-based anti-immigration content on Twitter with rapid spread and high polarizationon September 4, 2024 at 6:25 pm
A study of more than 200,000 tweets from 2019 and 2020 finds that anti-immigration content spreads faster than pro-immigration tweets and that a few users disproportionally generated most of the UK-based anti-immigration content. Andrea Nasuto and Francisco Rowe of the Geographic Data Science Lab at the University of Liverpool, UK, present these findings in the
- Agriculture accelerated human genome evolution to capture energy from starchy foodson September 4, 2024 at 6:23 pm
Over the past 12,000 years, humans in Europe have dramatically increased their ability to digest carbohydrates, expanding the number of genes they have for enzymes that break down starch from an average of eight to more than 11, according to a new study by researchers from the U.S., Italy and United Kingdom. Credit: Peter Sudmant,
- As dogs age, their owner-assessed quality of life predictably declines, with higher mortality seen at quality of life below 76% of the maximum score – though many dogs have high quality of life even when at predicted lifespanon September 4, 2024 at 6:19 pm
As dogs age, their owner-assessed quality of life predictably declines, with higher mortality seen at quality of life below 76% of the maximum score – though many dogs have high quality of life even when at predicted lifespan Credit: Juli Leonard for the Canine Neuroaging Program, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) As dogs age, their owner-assessed quality
- Samples from bottled water, tap water and household-treated tap water in San Francisco Bay Area indicate that all sources may have potential health risks, largely from trihalomethaneson September 4, 2024 at 6:17 pm
Samples from bottled water, tap water and household-treated tap water in San Francisco Bay Area indicate that all sources may have potential health risks, largely from trihalomethanes. Credit: SimpleLab, Inc. Redistribution permitted with credit given to the creator, SimpleLab, Inc. Samples from bottled water, tap water and household-treated tap water in San Francisco Bay Area
- Young male northern elephant seals are captured on camera returning to a deep sea cabled observatory off Canada’s British Columbia coast, demonstrating new insight into fish foraging behavioron September 4, 2024 at 6:13 pm
Young male northern elephant seals are captured on camera returning to a deep sea cabled observatory off Canada’s British Columbia coast, demonstrating new insight into fish foraging behavior Credit: Ocean Networks Canada, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) Young male northern elephant seals are captured on camera returning to a deep sea cabled observatory off Canada’s British Columbia
- Both cats and dogs often enjoy playing fetch with their ownerson September 4, 2024 at 6:11 pm
Although more common in dogs, 4 in 10 pet cats also choose to play fetch with their owners, Mikel Delgado from Purdue University, US, and colleagues report in the open-access journal PLOS ONE, publishing September 4, 2024. Credit: Leeza Kolesnikov, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/) Although more common in dogs, 4 in 10 pet cats also choose
- Collaborative research to benefit coastal flounder populations and fisherson September 4, 2024 at 6:09 pm
Four faculty members from three departments in the College of Natural Resources and Environment have received $1.7 million from the National Science Foundation to fund research into the dynamics of socio-environmental factors impacting coastal fisheries. Credit: Photo by Lee Friesland for Virginia Tech. Four faculty members from three departments in the College of Natural Resources
- New book ‘Macroevolutionaries’ explores intersection of evolution, art and popular cultureon September 4, 2024 at 5:13 pm
LAWRENCE — A new book of natural history essays co-written by a University of Kansas paleontologist has been published by Columbia University Press. Credit: Columbia University Press LAWRENCE — A new book of natural history essays co-written by a University of Kansas paleontologist has been published by Columbia University Press. Bruce Lieberman, Dean’s Professor of Evolutionary Biology
- SpinMagIC: ‘EPR on a chip’ ensures quality of olive oil and beeron September 4, 2024 at 5:10 pm
The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and
- City of Hope to offer second opinions for cancer patients in Southeast Asia via a collaboration agreement with the Healthway Cancer Care Hospitalon September 4, 2024 at 5:08 pm
LOS ANGELES — Oncology specialists at City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, can now provide leading-edge clinical guidance to patients living in Southeast Asia through a second opinion collaboration agreement with the Healthway Cancer Care Hospital, the first comprehensive cancer hospital in
- A new role for intelligent tutors powered by AI in brain surgery? on September 4, 2024 at 4:17 pm
Neurosurgery is perhaps one of the most demanding professions in healthcare. Surgeons spend long hours performing operations where expert performance means the difference between a good and bad patient outcome. While operative injuries are rare, when they occur, they can have serious, and lifelong consequences. Credit: The Neuro Neurosurgery is perhaps one of the most
- At-risk butterflies more likely to survive with human helpon September 4, 2024 at 4:11 pm
VANCOUVER, Wash. – Some of the butterflies most in danger of fluttering out of existence fare better when their habitats are actively managed by humans, a recent study found. Credit: Photo by Shelly Hanks, Washington State University VANCOUVER, Wash. – Some of the butterflies most in danger of fluttering out of existence fare better when
- PFAS influence the development and function of the brainon September 4, 2024 at 4:07 pm
Because of their special properties – heat resistance, water and grease repellence, and high durability – PFAS are used in many everyday products (e.g. cosmetics, outdoor clothing, and coated cookware). But it is precisely these properties that make them so problematic. “Because some PFAS are chemically stable, they accumulate in the environment and enter our